| PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance V Verma, RK Shrimali, S Ahmad, W Dai, H Wang, S Lu, R Nandre, P Gaur, ... Nature immunology 20 (9), 1231-1243, 2019 | 255 | 2019 |
| Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniae B5055: A Potential Therapeutic Agent V Verma, K Harjai, S Chhibber Current microbiology 59, 274-281, 2009 | 155 | 2009 |
| Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis RK Shrimali, S Ahmad, V Verma, P Zeng, S Ananth, P Gaur, RM Gittelman, ... Cancer immunology research 5 (9), 755-766, 2017 | 146 | 2017 |
| Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055 MS Bedi, V Verma, S Chhibber World Journal of Microbiology and Biotechnology 25, 1145-1151, 2009 | 133 | 2009 |
| Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae V Verma, K Harjai, S Chhibber Biofouling 26 (6), 729-737, 2010 | 124 | 2010 |
| Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment V Verma, K Harjai, S Chhibber Journal of Antimicrobial Chemotherapy 64 (6), 1212-1218, 2009 | 121 | 2009 |
| MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects V Verma, N Jafarzadeh, S Boi, S Kundu, Z Jiang, Y Fan, J Lopez, ... Nature immunology 22 (1), 53-66, 2021 | 118 | 2021 |
| Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy S Ahmad, R Abu-Eid, R Shrimali, M Webb, V Verma, A Doroodchi, ... Cancer research 77 (8), 1892-1904, 2017 | 106 | 2017 |
| Alternative formats CT Nguyen, SH Hong, TT Ung, V Verma, SY Kim, JH Rhee, SE Lee Korean J Physiol Pharmacol 15 (3), 179-187, 2011 | 92* | 2011 |
| Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression V Verma, Y Kim, MC Lee, JT Lee, S Cho, IK Park, JJ Min, JJ Lee, SE Lee, ... Oncotarget 7 (26), 39894, 2016 | 38 | 2016 |
| Molecular characterization of vulnibactin biosynthesis in Vibrio vulnificus indicates the existence of an alternative siderophore W Tan, V Verma, K Jeong, SY Kim, CH Jung, SE Lee, JH Rhee Frontiers in Microbiology 5, 1, 2014 | 34 | 2014 |
| Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer SE Lee, SH Hong, V Verma, YS Lee, TMN Duong, K Jeong, S Uthaman, ... OncoImmunology 5 (just-accepted), e1081328, 2015 | 33 | 2015 |
| Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB V Verma, W Tan, S Puth, KO Cho, SE Lee, JH Rhee Journal of translational medicine 14, 1-12, 2016 | 21 | 2016 |
| Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model CT Nguyen, SH Hong, TT Ung, V Verma, SY Kim, JH Rhee, SE Lee Clinical and Experimental Vaccine Research 2 (2), 128, 2013 | 18 | 2013 |
| IDO vaccine ablates immune-suppressive myeloid populations and enhances antitumor effects independent of tumor cell IDO status R Nandre, V Verma, P Gaur, V Patil, X Yang, Z Ramlaoui, N Shobaki, ... Cancer immunology research 10 (5), 571-580, 2022 | 17 | 2022 |
| u-CARE: user-friendly Comprehensive Antibiotic resistance Repository of Escherichia coli SB Saha, V Uttam, V Verma Journal of clinical pathology 68 (8), 648-651, 2015 | 17 | 2015 |
| More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization HS Hwang, S Puth, W Tan, V Verma, K Jeong, SE Lee, JH Rhee Human vaccines & immunotherapeutics 14 (9), 2194-2202, 2018 | 15 | 2018 |
| An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation S Puth, V Verma, SH Hong, W Tan, SE Lee, JH Rhee Biomaterials 286, 121542, 2022 | 12 | 2022 |
| Maternal obesity increases offspring’s mammary cancer recurrence and impairs tumor immune response X Zhang, F de Oliveira Andrade, H Zhang, I Cruz, R Clarke, P Gaur, ... Endocrine-related cancer 27 (9), 469-482, 2020 | 12 | 2020 |
| CXCR4 antagonist (BL-8040) to enhance antitumor effects by increasing tumor infiltration of antigen-specific effector T-cells. P Gaur, V Verma, S Gupta, E Sorani, A Vainstein Haras, G Oberkovitz, ... Journal of Clinical Oncology 36 (5_suppl), 73-73, 2018 | 11 | 2018 |
Joon Haeng RheeDepartment of Microbiology, Chonnam National University Medical SchoolVerified email at chonnam.ac.kr
